Physician profile
Christopher M Happ
NPI 1154561702
$104,749.26
in general payments reported to CMS, 2019-2025
22 companies · $508 in 2025
The $508 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,099 · 2020: $4,270 · 2021: $29K · 2022: $28K · 2023: $31K · 2024: $8,493 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $36K · Consulting Fee: $2,975 · Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $35,750.24 |
| Consulting Fee | $2,975.00 |
| Food and Beverage | $1,182.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $93,890.47 | 2020-2024 | Foot and Ankle, Focus |
| Kyocera Medical Technologies, INC. | $3,578.32 | 2021-2025 | |
| Nanohive Medical LLC | $3,378.53 | 2019 | |
| Centinel Spine, LLC | $1,127.82 | 2021-2024 | Prodisc C Sk, Prodisc L |
| Nevro Corp. | $865.98 | 2019-2024 | Senza |
| Camber Spine Technologies LLC | $612.75 | 2021 | |
| Globus Medical, INC. | $352.09 | 2021-2025 | Senza, Omnia |
| Providence Medical Technology, INC. | $172.26 | 2022-2025 | |
| Osseus Fusion Systems, LLC | $150.36 | 2019 | |
| Intrinsic Therapeutics | $146.82 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic, INC. | $110.45 | 2021-2023 | Cd Horizon Spinal System |
| Spineology INC. | $62.65 | 2025 | |
| Nuvasive, INC. | $44.81 | 2019 | |
| Boston Scientific Corporation | $40.69 | 2021 | |
| Baxter Healthcare | $34.51 | 2024 | Floseal |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $33.88 | 2019 | |
| Stryker Corporation | $31.74 | 2021 | |
| Theragen, INC. | $31.68 | 2024-2025 | Actastim-S |
| Horizon Therapeutics Plc | $31.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.10 | 2020 | |
| Argentum Medical | $18.10 | 2021 | |
| Bioventus LLC | $14.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Happ listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.